Anal cancer, Bowel (colorectal) cancer, Breast cancer, Cervical cancer, Lung cancer, Mesothelioma, Salivary gland cancer, Small cell lung cancer, Womb (uterine or endometrial) cancer
Results
Phase 2
This trial looked at pembrolizumab for certain types of advanced cancer.
It was for people whose cancer had large amounts of a substance called PD-L1.
This trial was open for people to join between April 2014 and August 2015. The results of the trial were published in 2017 and 2018.
Recruitment start: 1 April 2014
Recruitment end: 25 August 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rhoda Molife
Experimental Cancer Medicine Centre (ECMC)
Merck Sharp & Dohme Ltd
Last reviewed: 23 Sept 2020
CRUK internal database number: 11969
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
